Back to
RA CAPITAL MANAGEMENT, L.P.
ANTX12 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in AN2 THERAPEUTICS INC
No. RA Capital Management exited its ANTX (AN2 Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 1,999,997 shares worth $2.1M. RA Capital Management first reported ANTX in Q1 2022 and held it in 11 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$55.3M
Total Shares Change
-3.7M
Quarter-by-Quarter History
Other major holders of ANTX: CITADEL ADVISORS LLC, Janus Henderson Group Ltd.